Advantages of FBPA PET in evaluating early response of anti-PD-1 immunotherapy in B16F10 melanoma-bearing mice: Comparison to FDG PET

PURPOSE: PET with L-4-borono-2-[(18)F] fluoro-phenylalanine (FBPA) was reported to be useful to differentiate malignant tumors and inflammation. Although immunotherapy with immune checkpoint inhibitors (ICIs) has been applied to cancer treatment recently, FDG PET may not be suitable to determine the...

Descripción completa

Detalles Bibliográficos
Autores principales: Tatsumi, Mitsuaki, Soeda, Fumihiko, Naka, Sadahiro, Kurimoto, Kenta, Ooe, Kazuhiro, Fukui, Hideyuki, Katayama, Daisuke, Watabe, Tadashi, Kato, Hiroki, Tomiyama, Noriyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815495/
https://www.ncbi.nlm.nih.gov/pubmed/36620558
http://dx.doi.org/10.3389/fonc.2022.1026608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815495/
https://www.ncbi.nlm.nih.gov/pubmed/36620558
http://dx.doi.org/10.3389/fonc.2022.1026608

Ejemplares similares